Brief: Larimar Therapeutics Announces Issuance Of U.S. Patent Providing Composition Of Matter Protection For CTI-1601

Larimar Therapeutics

20/10/2022 13:20

Oct 20 (Reuters) - Larimar Therapeutics Inc  LRMR.O :
    * ANNOUNCES ISSUANCE OF U.S. PATENT PROVIDING COMPOSITION OF
MATTER PROTECTION FOR CTI-1601
    * PATENT EXTENDS LARIMAR'S INTELLECTUAL PROPERTY PROTECTION
FOR
CTI-1601 INTO AT LEAST JULY 2040
    * HAS AN EXCLUSIVE LICENSE TO PATENT PER A PRIOR AGREEMENT
WITH
INDIANA UNIVERSITY

Source text for Eikon:  ID:nGNX8j6WV6 
Further company coverage:  LRMR.O 
 ((Reuters.Briefs@thomsonreuters.com;))